(2026) -
Chronological (1715 items)
(All links open in new tab)
| Oct 18, 2026 |
Why Is Marijuana Regulated More Strictly Than Alcohol, Even Though It Is Safer To Use? (Op-Ed)
I read the commentary piece by Robert Mellion, executive director of the Massachusetts Package Stores Association, with great bemusement. He argues that oversight of the state’s cannabis sector has been lax and that it should be regulated like alcohol. I think he has it backwards in two fundamental ways. First, alcohol is a much more deadly intoxicant than cannabis. Full stop. It’s worth wondering out loud whether alcohol and cannabis should have the same regulatory regime. Under the existing legal cannabis industry, there have been zero reported deaths from legal cannabis use. The same is not true of alcohol use. Second, cannabis is regulated more comprehensively than virtually any other retail product sold in Massachusetts. |
|---|---|
| Oct 17, 2026 |
The first plant-based medical THC spray arrives in the United Kingdom
The Irish pharmaceutical laboratory Dunbar Pharma launches the country's first plant-based THC mouth spray. Made by its British partner IPS Pharma, this new formulation offers an additional administration option to medical specialists, just two months after the launch of THC capsules by the two companies. |
| Oct 17, 2026 |
Moroccan tycoon Lamia Tazi's Sothema wins approval for three cannabis epilepsy drugs
Moroccan pharmaceutical tycoon Lamia Tazi's Sothema, the Casablanca-listed drugmaker controlled by the Tazi and Berrada families, has won marketing authorisations for three cannabis-based medicines to treat epilepsy, its first approvals in the medical cannabis business it has been building for the past several years. The drugs were developed with the Fondation Mohammed VI des Sciences et de la Santé, a Moroccan health and research foundation. None of them is on sale in Morocco yet. Sothema has not disclosed their brand names, formulations, prices or launch dates, or whether the national health insurance scheme will reimburse them. |
| Oct 17, 2026 |
OPINION: Canada’s legal cannabis system has an access problem hiding in plain sight
Eight years after cannabis legalization, Canadians seeking CBD for health-related reasons are still caught between two systems that weren’t built for them. In the recreational market, non-intoxicating products and the people looking for them have been squeezed to the margins of a retail system that rewards high THC and fast sales. Shelf space goes to what moves: an August 2026 review of Ontario’s cannabis catalogue found that just 1.2% of listings were THC-free. OCS data also shows that roughly 80% of new listings are phased out within a year. |
| Oct 17, 2026 |
Medical Cannabis in Germany: THC Prices Vary by a Factor of 12
The price of medical cannabis in Germany varies considerably depending on the formulation: one milligram of THC can cost between €0.12 and €1.40. A new comparative study conducted by the Working Group on Medical Cannabis (Working Group on Cannabis as Medicine – ACM) highlights substantial differences between approved drugs, cannabis extracts, and compounding preparations. |
| Oct 16, 2026 |
Eight Years of Legalization: Canada’s Abandoned Cannabis Policy and Unfinished Industry
The federal government has abandoned cannabis. Not only the industry, but the policy itself. In the lead-up to legalization on October 17, 2018, there was enormous political will and momentum to approach legalization through a public-health lens. But almost immediately after the law took effect, that momentum quickly began to wither. |
| Oct 16, 2026 |
Why Cannabis Stocks Are Looking Dirt Cheap
What does cannabis have to do with disruptive technology investing? Many people ask that question when they see we cover cannabis alongside more than 50 disruptive technology themes. Cannabis is neither a technology nor disruptive, though some might argue it disrupts those who consume too much of it. The backstory behind why we cover cannabis is worth telling because it surrounded the biggest hype cycle we’ve ever seen. |
| Oct 16, 2026 |
The Status of Federal Cannabis Rescheduling
On December 18, 2025 President Trump signed an executive order directing federal agencies to begin expediting the process of rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act.[1] This decision follows years of federal review and empty promises from multiple administrations as medical and retail sales of marijuana have expanded to 40 states and the District of Columbia. Updates since Trump’s announcement have been sparse. |
| Oct 16, 2026 |
Most Pre-Rolls Suck. Josh Kesselman Thinks He Found the Fix, and He Wants the Industry to Copy Him.
Three people who judge cannabis for a living were asked separately what’s wrong with the pre-roll aisle. None knew what the others had said. They landed in almost exactly the same place. Then one of them built a fix and published it so his competitors could steal it. |
| Oct 16, 2026 |
Kentucky Now Has Medical Marijuana Dispensaries Open In Every Region Of The State, Governor Announces
The governor of Kentucky announced on Friday that medical marijuana dispensaries are now open across all 11 licensing regions of the state following the opening of Sunnyside Dispensary in Floyd County this week. “Kentuckians suffering from PTSD, cancer, terminal illnesses, sickle cell anemia and more deserve a safe, non-addictive option for relief, and medical cannabis provides that,” Gov. Andy Beshear (D) said. |
| Oct 16, 2026 |
Morocco revokes 1,490 cannabis licenses amid 2026 harvest and European market push
Morocco's National Agency for the Regulation of Cannabis-Related Activities has revoked 1,490 licenses tied to the country's legal cannabis sector for noncompliance with applicable procedures and regulations, as the 2026 harvest moves forward across the country's three regulated provinces. Of the total licenses withdrawn, nearly 1,300 belonged to cannabis growers and 190 to other operators across the supply chain. The 190 non-grower licenses cover seed imports (60), processing and manufacturing (45), marketing (35), exports (31), seed exports (12) and transportation (7). |
| Oct 15, 2026 |
Cannabis and Health: How Cannabinoids Affect the Human Body
Introduction Researchers are increasingly exploring cannabinoids as bioactive dietary compounds with potential applications in nutrition and health. As research into hemp-derived ingredients expands, scientists are investigating how non-intoxicating cannabinoids interact with the endocannabinoid system (ECS) and other signaling pathways to influence metabolism, inflammation, and disease.2,3 |
| Oct 15, 2026 |
France already has 3,000 cannabis retail outlets. None of them are legal.
France has thousands of drug dealing spots, five million annual cannabis users, and a market worth several billion euros. Yet the sale of cannabis to adults remains illegal. This paradox is reflected in the official figures. According to the Mapping of the Drug Trade in France in 2024 According to government data, there were approximately 3,000 points of sale across the country. This figure includes all types of narcotics, not just cannabis, but it gives an idea of the scale of the distribution networks. |
| Oct 15, 2026 |
Chile’s Cannabis Social Clubs Are Booming In A Legal Gray Area
Cannabis social clubs are taking off across Chile, yet they continue to operate in a precarious legal gray area that leaves their future hanging in the balance. Over the past decade, the number of registered cannabis social clubs shot up to at least 294 by late 2024, spread across all 16 regions of the South American country, according to a study published in the Journal of Cannabis Research in September. Although 67.3% of these clubs are concentrated in the Santiago Metropolitan Region, 2024 alone saw a record 71 new registrations nationwide—most of them in Santiago and Las Condes. |
| Oct 15, 2026 |
Competing Canadian Trademark Filings Spark Brand Name Dispute Over Cannabis Products
Sidekick Analytics, an independent cannabis product developer and brand owner based in Ontario, is involved in a priority battle with multinational consumer packaged goods company Tilray Brands Inc. over conflicting claims to the PORTALS brand name. Dan Black launched the PORTALS brand under Sidekick Analytics and managed its formulation, compliance, packaging, and sales. By 2023, PORTALS-branded products, including tablets and edibles, were sold commercially in Ontario, BC, and Alberta, generating what he says was nearly $3 million in retail sales. |
| Oct 15, 2026 |
Marijuana Is A Popular Tool For People Trying To Quit Smoking Cigarettes, Rivaling Prescription Nicotine Cessation Medications, Study Shows
Almost as many people are using marijuana to help them quit smoking cigarettes as are using prescription nicotine cessation aids, according to a new study conducted by officials with the U.S. Department of Veterans Affairs (VA) and other institutions. The research, however, raises questions about potential side effects experienced by people who are using cannabis to quit tobacco products. |
| Oct 15, 2026 |
Nearly one-third of cannabis consumers say they have completely cut out alcohol
Nearly one-third of cannabis consumers say they have completely replaced alcohol with cannabis, while almost two-thirds report drinking less as a result of their cannabis use, according to a new survey conducted in the United States. The poll was conducted as part of Sober October, an annual initiative encouraging people to abstain from alcohol for a month, by medical cannabis telehealth company NuggMD. Over 1000 cannabis consumers were polled between 24 and 26 September 2026. |
| Oct 15, 2026 |
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company
TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabis company, today announced that it has completed its previously announced acquisition of CanAdelaar B.V. ("CanAdelaar"), the largest cannabis company operating within the Netherlands' adult-use cannabis pilot program, the Wietexperiment. |
| Oct 15, 2026 |
Irradiated Medical Cannabis and the Science Behind the Debate
Much of the discussion involving irradiated medical cannabis centres on whether the treatment affects THC or terpenes. Those are reasonable questions, but I think the microbiology deserves an equal share of the attention. Irradiation can substantially reduce the number of viable microorganisms in flower, but any mould that has already grown remains physically present after treatment. |
| Oct 15, 2026 |
Cannabis doesn’t make you violent – despite what recent reports have claimed
n what looked like a return to the dark days of Reefer Madness – a 1936 film that portrayed cannabis as a drug that could drive people to madness and murder – a recent article in the Daily Telegraph claimed that cannabis users are “twice as likely to be violent”. The claim comes from a systematic review by King’s College London that combined 63 studies covering more than 265,000 people. The researchers did, indeed, find a link between cannabis use and violence, but the headline overstates what the numbers can tell us. There are three reasons to be cautious: other factors that could explain the link (known as confounders), the way the studies were designed, and potential biases in how the data was gathered. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86